SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Pharma informs about outcome of board meeting

29 Jan 2026 Evaluate

With reference to its letter dated 16th January, 2026. Pursuant to Regulation 33 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Piramal Pharma has informed that the Board of Directors of the Company at its meeting held today, 28th January, 2026, has approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December, 2025. In this regard, it has enclosed the following: a. Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2025; b. Limited Review Reports by the Statutory Auditor. Further, the company is arranging to publish details of the above-mentioned financial results in newspapers as per Regulation 47 of the SEBI Listing Regulations. The above information is also available on the website of the Company at www.piramalpharma.com. The meeting of the Board commenced at 5:30 pm and concluded at 10.00 pm.

The above information is a part of company’s filings submitted to BSE.

Piramal Pharma Share Price

148.90 1.45 (0.98%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×